OpenAI COO Shifts Out of Role, AGI CEO Taking Medical Leave

OpenAI’s COO is transitioning to a new role, reshaping the company’s leadership structure as it prepares for a potential Wall Street IPO later this year. Two top executives, including the CEO of its AGI division, are taking medical leave, raising questions about internal stability during a critical growth phase. The leadership changes come amid OpenAI’s aggressive push toward commercialization and regulatory scrutiny, complicating its strategic timeline. The departures and role shifts may impact investor confidence ahead of the anticipated public offering, though no official delay has been announced. Analysts speculate the moves could signal broader operational challenges as OpenAI scales its AI infrastructure and navigates market expectations.